Joachim Brom

511 total citations
13 papers, 323 citations indexed

About

Joachim Brom is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, Joachim Brom has authored 13 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 6 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Joachim Brom's work include Venous Thromboembolism Diagnosis and Management (5 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (3 papers). Joachim Brom is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (5 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (3 papers). Joachim Brom collaborates with scholars based in Germany. Joachim Brom's co-authors include Gottfried Weidinger, Manfred Köller, Wolfgang König, E. Bernd Ringelstein, H. Landgraf, Rüdiger von Kummer, Michael Gräve, Job Harenberg, Michael G. Hennerici and Hans‐Christoph Diener and has published in prestigious journals such as Circulation, Stroke and Biochemical and Biophysical Research Communications.

In The Last Decade

Joachim Brom

13 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joachim Brom Germany 10 136 132 122 63 46 13 323
V. De Mitrio Italy 9 53 0.4× 99 0.8× 57 0.5× 23 0.4× 16 0.3× 12 304
V. Pagliara Italy 8 44 0.3× 56 0.4× 183 1.5× 55 0.9× 27 0.6× 8 297
Margit Tökés‐Füzesi Hungary 13 72 0.5× 49 0.4× 245 2.0× 146 2.3× 52 1.1× 26 498
G. Liakos Greece 4 45 0.3× 51 0.4× 247 2.0× 41 0.7× 21 0.5× 4 313
Kenkichi Miyahara Japan 9 139 1.0× 79 0.6× 458 3.8× 111 1.8× 23 0.5× 43 571
Costin Ionescu United States 9 33 0.2× 28 0.2× 95 0.8× 135 2.1× 16 0.3× 23 293
Katarzyna Ptaszyńska‐Kopczyńska Poland 10 43 0.3× 21 0.2× 146 1.2× 35 0.6× 35 0.8× 25 258
Thomas Luebke Germany 12 39 0.3× 45 0.3× 101 0.8× 144 2.3× 38 0.8× 21 370
Lisa M. Smith United States 11 41 0.3× 43 0.3× 485 4.0× 41 0.7× 46 1.0× 19 602
Per Leth-Espensen Denmark 6 95 0.7× 23 0.2× 71 0.6× 123 2.0× 15 0.3× 9 376

Countries citing papers authored by Joachim Brom

Since Specialization
Citations

This map shows the geographic impact of Joachim Brom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joachim Brom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joachim Brom more than expected).

Fields of papers citing papers by Joachim Brom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joachim Brom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joachim Brom. The network helps show where Joachim Brom may publish in the future.

Co-authorship network of co-authors of Joachim Brom

This figure shows the co-authorship network connecting the top 25 collaborators of Joachim Brom. A scholar is included among the top collaborators of Joachim Brom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joachim Brom. Joachim Brom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Diener, Hans‐Christoph, E. Bernd Ringelstein, Rüdiger von Kummer, et al.. (2005). Prophylaxis of Thrombotic and Embolic Events in Acute Ischemic Stroke With the Low-Molecular-Weight Heparin Certoparin. Stroke. 37(1). 139–144. 55 indexed citations
3.
4.
Harenberg, Job, Hanno Riess, Harry R. Büller, et al.. (2003). Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.. PubMed. 88(10). 1157–62. 6 indexed citations
5.
Diener, Hans‐Christoph, E. Bernd Ringelstein, Rüdiger von Kummer, et al.. (2001). Treatment of Acute Ischemic Stroke With the Low-Molecular-Weight Heparin Certoparin. Stroke. 32(1). 22–29. 81 indexed citations
6.
Carlsson, J., et al.. (2000). Prior Cytomegalovirus, Chlamydia pneumoniae or Helicobacter pylori infection and the risk of restenosis after percutaneous transluminal coronary angioplasty. International Journal of Cardiology. 73(2). 165–171. 19 indexed citations
7.
Essen, R. von, Eberhard Grube, W Mäurer, et al.. (1997). Effects of Octreotide Treatment on Restenosis After Coronary Angioplasty. Circulation. 96(5). 1482–1487. 31 indexed citations
8.
Brom, Joachim, et al.. (1993). GTP-binding proteins in polymorphonuclear granulocytes of severely burned patients. Journal of Leukocyte Biology. 53(3). 268–272. 9 indexed citations
9.
Köller, Manfred, et al.. (1989). Studies on the Mechanisms of Granulocyte Dysfunctions in Severely Burned Patients—Evidence for Altered Leukotriene Generation. The Journal of Trauma: Injury, Infection, and Critical Care. 29(4). 435–445. 17 indexed citations
10.
Köller, Manfred, Wolfgang König, Joachim Brom, et al.. (1988). Generation of Leukotrienes from Human Polymorphonuclear Granulocytes of Severely Burned Patients. The Journal of Trauma: Injury, Infection, and Critical Care. 28(6). 733–740. 22 indexed citations
11.
Köller, Manfred, Joachim Brom, W. Schönfeld, J. Knöller, & Wolfgang König. (1986). Studies on the Degradation of Imipenem Within Serum and a Renal Kidney Fraction. Zentralblatt für Bakteriologie Mikrobiologie und Hygiene Series A Medical Microbiology Infectious Diseases Virology Parasitology. 261(3). 330–337. 3 indexed citations
12.
Köller, Manfred, et al.. (1985). Functional characteristics of leukotriene C4- and D4 -metabolizing enzymes (γ-glutamyl transpeptidase, dipeptidase) within human plasma. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 836(1). 56–62. 13 indexed citations
13.
Köller, Manfred, Joachim Brom, Monika Raulf, & Wolfgang König. (1985). Cilastatin (MK 0791) is a potent and specific inhibitor of the renal leukotriene D 4 -dipeptidase. Biochemical and Biophysical Research Communications. 131(2). 974–979. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026